Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas
Not Applicable
- Conditions
- Glioma
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Hebei Yanda Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02771301
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, Beijing, China
🇨🇳Hebei Yanda Hospital, Sanhe, Hebei, China
Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
Not Applicable
- Conditions
- Recurrent High-grade Glioma
- Interventions
- First Posted Date
- 2015-04-15
- Last Posted Date
- 2016-02-18
- Lead Sponsor
- Hebei Yanda Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02416999
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, Beijing, China
🇨🇳Hebei Yanda Hospital, Sanhe, Hebei, China
A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation
Not Applicable
- Conditions
- Recurrent High-grade Glioma
- Interventions
- Drug: Lomustine/Vincristine/Procarbazine
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- Hebei Yanda Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT02333513
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, Beijing, China
🇨🇳Hebei Yanda Hospital, Sanhe, Hebei, China
News
No news found